<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title> non-alcoholic fatty liver disease | YZ Lab</title>
    <link>https://yz-lab.org/main/tag/non-alcoholic-fatty-liver-disease/</link>
      <atom:link href="https://yz-lab.org/main/tag/non-alcoholic-fatty-liver-disease/index.xml" rel="self" type="application/rss+xml" />
    <description> non-alcoholic fatty liver disease</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Fri, 01 May 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://yz-lab.org/main/media/icon_hued1f538d73f883b5373c8a98edb20792_18869_512x512_fill_lanczos_center_3.png</url>
      <title> non-alcoholic fatty liver disease</title>
      <link>https://yz-lab.org/main/tag/non-alcoholic-fatty-liver-disease/</link>
    </image>
    
    <item>
      <title>The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue</title>
      <link>https://yz-lab.org/main/publication/refworks1475/</link>
      <pubDate>Fri, 01 May 2020 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1475/</guid>
      <description>&lt;p&gt;LR: 20200518; CI: (c) 2020; GR: Novo Nordisk Foundation; GR: EU H2020-JTI-IMI2 project 777377-2 Liver Investigation: Testing Marker Utility in Steatohepatitis; GR: FS/15/56/31645/BHF_/British Heart Foundation/United Kingdom; GR: 634413/EU H2020 project &amp;lsquo;Elucidating Pathways of Steatohepatitis&amp;rsquo;; GR: Sigrid Juselius Foundation; GR: EVO; GR: 309263/Academy of Finland; JID: 101160857; OTO: NOTNLM; 2020/04/02 00:00 [received]; 2020/04/23 00:00 [revised]; 2020/05/02 00:00 [accepted]; 2020/05/10 06:00 [pubmed]; 2020/05/10 06:00 [medline]; 2020/05/10 06:00 [entrez]; aheadofprint&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD</title>
      <link>https://yz-lab.org/main/publication/refworks1426/</link>
      <pubDate>Sat, 01 Jul 2017 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1426/</guid>
      <description>&lt;p&gt;LR: 20170619; CI: Copyright (c) 2017; JID: 8503886; OTO: NOTNLM; 2016/11/28 [received]; 2017/02/07 [revised]; 2017/02/10 [accepted]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans</title>
      <link>https://yz-lab.org/main/publication/refworks1419/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1419/</guid>
      <description>&lt;p&gt;LR: 20170126; JID: 7608063; OTO: NOTNLM; 2016/09/21 [received]; 2016/11/11 [accepted]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease</title>
      <link>https://yz-lab.org/main/publication/refworks1402/</link>
      <pubDate>Sun, 01 May 2016 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1402/</guid>
      <description>&lt;p&gt;CI: Copyright (c) 2016; JID: 8503886; OTO: NOTNLM; 2015/07/28 [received]; 2015/11/05 [revised]; 2016/01/04 [accepted]; 2016/01/11 [aheadofprint]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease</title>
      <link>https://yz-lab.org/main/publication/refworks1420/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1420/</guid>
      <description>&lt;p&gt;LR: 20160106; CI: (c) 2015; JID: 101607800; 0 (MicroRNAs); OID: NLM: PMC4760405; OTO: NOTNLM; GN: NLM: Original DateCompleted: 20160106; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>A population-based study on the prevalence of NASH using scores validated against liver histology</title>
      <link>https://yz-lab.org/main/publication/refworks1314/</link>
      <pubDate>Tue, 01 Apr 2014 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1314/</guid>
      <description>&lt;p&gt;CI: Copyright (c) 2014; JID: 8503886; OTO: NOTNLM; 2013/08/02 [received]; 2013/11/27 [revised]; 2013/12/04 [accepted]; 2013/12/12 [aheadofprint]; ppublish&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
